Bio-Techne, Wilson Wolf, and CellReady awarded a $300,000 G-Rex Grant to Stanford Medicine’s LCGM for CAR-T cell therapy manufacturing. The grant is part of a $20 million initiative to support CGT development. Eligible recipients receive supplies, support, and discounts. Stanford Medicine LCGM plans to use the grant for a Phase I trial and potency testing. Feldman from Stanford Medicine LCGM expressed the grant’s importance for future clinical trials. Wilson from Wilson Wolf praised Stanford University’s reputation for innovation.
Bio-Techne, Wilson Wolf, and CellReady awarded a $300,000 G-Rex Grant to Stanford Medicine’s LCGM for CAR-T cell therapy manufacturing. The grant is part of a $20 million initiative to support CGT development. Eligible recipients receive supplies, support, and discounts. Stanford Medicine LCGM plans to use the grant for a Phase I trial and potency testing. Feldman from Stanford Medicine LCGM expressed the grant’s importance for future clinical trials. Wilson from Wilson Wolf praised Stanford University’s reputation for innovation.